Pharmaceutical policy Part 1 The challenge to pharmacists to engage in policy development

被引:7
作者
Morrow N.C. [1 ]
机构
[1] Commonwealth Pharmacists Association, 1 Lambeth High Street, London
关键词
Cost effectiveness; Medication safety; Medicines management; Patient involvement; Patient utilisation; Pharmaceutical policy; Pharmacists; Prescribing; Strategic planning;
D O I
10.1186/s40545-015-0027-5
中图分类号
学科分类号
摘要
Across the world medicines are the ubiquitous technology in the diagnosis, treatment and prevention of disease. Pharmaceutical policy, as part of national health care policy, is concerned with the provision and use of medicines. Pharmacists are critical to the medicines management process, yet are often largely detached from policy development. Logically, they should inform Government policies which impact on their work or where their skills could be best applied to implement health care policy and medicines utilisation in particular. It therefore makes it critically important that the pharmaceutical profession engages with national policy makers and in the strategic planning for health care. This is the first of two articles directed to this specific issue. Firstly, it identifies a number of the practice challenges for pharmacy and medicines management, their implications for policy and the need for a balanced approach. Drawing from a range of international experiences some key learning points in respect of formulating and implementing national medicines policies are presented. Finally, reference is made to several authoritative evidence bases to inform the development of pharmaceutical practice and medicines management policies. © 2015 Morrow; licensee BioMed Central.
引用
收藏
页码:1 / 6
页数:5
相关论文
共 50 条
[41]   Public attitude and knowledge on a new health policy for pharmaceutical care in Korea [J].
Kang, HY ;
Park, CY ;
Kim, HJ .
HEALTH POLICY, 2002, 62 (02) :195-209
[42]   Access to medicines in Colombia and the contours of a right and a pharmaceutical policy halfway through [J].
Figueredo De Perez, Daniel Andres ;
Vargas Chaves, Ivan .
JUSTICIA, 2020, 25 (37) :125-149
[43]   Australian Pharmaceutical Policy: Price Control, Equity, and Drug Innovation in Australia [J].
Evan Doran ;
David Alexander Henry .
Journal of Public Health Policy, 2008, 29 :106-120
[44]   The Pharmaceutical Pricing and Reimbursement Information (PPRI) initiative-Experiences from engaging with pharmaceutical policy makers [J].
Vogler, Sabine ;
Leopold, Christine ;
Zimmermann, Nina ;
Habl, Claudia ;
de Joncheere, Kees .
HEALTH POLICY AND TECHNOLOGY, 2014, 3 (02) :139-148
[45]   Pharmacists' views on the development of asthma pharmaceutical care model in Indonesia: A needs analysis study [J].
Widayati, Aris ;
Virginia, Dita Maria ;
Setiawan, Christianus Heru ;
Fenty, Fenty ;
Donowati, Maria Wisnu ;
Christasani, Putu Dyana ;
Hartayu, Titien Siwi ;
Suhadi, Rita ;
Saini, Bandana ;
Armour, Carol .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2018, 14 (12) :1172-1179
[46]   Evaluation of the knowledge and attitude of pharmacists about the national malaria control policy in southern Benin [J].
Ganfon, Habib ;
Ekanmian, Giraud ;
Amoussou, Louis ;
Daniel-Garcia, Emilie ;
Allabi, Aurel Constant .
MALARIA JOURNAL, 2017, 16
[47]   A policy of free access to asthma medicines in Brazil: an opportunity for pharmacists to optimize asthma treatment [J].
Pablo Moura Santos ;
Lúcia Noblat ;
Álvaro A. Cruz .
International Journal of Clinical Pharmacy, 2013, 35 :510-512
[48]   A policy of free access to asthma medicines in Brazil: an opportunity for pharmacists to optimize asthma treatment [J].
Moura Santos, Pablo ;
Noblat, Lucia ;
Cruz, Alvaro A. .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (04) :510-512
[49]   The Belgian commitment to pharmaceutical quality: a model policy to improve quality assurance of medicines available through humanitarian and development programs [J].
Raffaella Ravinetto ;
Tim Roosen ;
Catherine Dujardin .
Journal of Pharmaceutical Policy and Practice, 11 (1)
[50]   The Belgian commitment to pharmaceutical quality: a model policy to improve quality assurance of medicines available through humanitarian and development programs [J].
Ravinetto, Raffaella ;
Roosen, Tim ;
Dujardin, Catherine .
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2018, 11 (01)